Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 74
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Phosphorylation by JNK switches BRD4 functions

Phosphorylation by JNK switches BRD4 functions

 60

Neural circuits for goal-directed navigation across species

Neural circuits for goal-directed navigation across spe...

 55

Comparative analysis of human and mouse ovaries across age

Comparative analysis of human and mouse ovaries across age

 17